review on glp-1 agonists and psychiatric effects Frontiers Exploring the Side Effects of
Description
Keywords: glucagon-like peptide-1 receptor, cinchonine, drug repurposing, non-alcoholic steatohepatitis, type 2 diabetes mellitus Graphical Abstract: Introduction Diabetes is a major threat to human health worldwide
Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness

True Value Score: A Pricing Medication Costs GLP1 medications are not included in membership fees
"FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight"
